Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mouridsen

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Sygeplejersken|September 28, 1977
[We should have a standard basic attitude to patients]I Albinus, M Bogart, J Knudsen, et al.
American Journal of Clinical Pathology|December 1, 1983
The value of routine biochemical and surgical pathology quantities in predicting recurrence in high-risk patients following surgery for primary breast cancerP Winkel, B E Statland, H Mouridsen, et al.
Cancer Treatment Reports|November 1, 1977
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancerM Hansen, T Palshof, K Osterlind, et al.
Clinical Chemistry|October 1, 1982
Predicting recurrence in patients with breast cancer from cumulative laboratory results: a new technique for the application of time series analysisP Winkel, M W Bentzon, B E Statland, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC Soft Tissue and Bone Sarcoma Group (STBSG)M Van Glabbeke, A T van Oosterom, W Steward, et al.
Acta Oncologica (Stockholm, Sweden)|November 28, 2000
A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanomaJ Baekke, C Rytter, H Mouridsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancerW Irish, B Sherrill, B Cole, et al.
Journal of Internal Medicine|September 1, 1992
Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized studyB Kristensen, B Ejlertsen, S N Holmegaard, et al.
British Journal of Cancer|July 1, 1994
Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screeningA H Andreasen, K W Andersen, M Madsen, et al.
Ugeskrift for Laeger|June 13, 2000
[Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?]N T Kroman, M B Jensen, J Wohlfahrt, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Sygeplejersken|September 28, 1977
[We should have a standard basic attitude to patients]I Albinus, M Bogart, J Knudsen, et al.
American Journal of Clinical Pathology|December 1, 1983
The value of routine biochemical and surgical pathology quantities in predicting recurrence in high-risk patients following surgery for primary breast cancerP Winkel, B E Statland, H Mouridsen, et al.
Cancer Treatment Reports|November 1, 1977
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancerM Hansen, T Palshof, K Osterlind, et al.
Clinical Chemistry|October 1, 1982
Predicting recurrence in patients with breast cancer from cumulative laboratory results: a new technique for the application of time series analysisP Winkel, M W Bentzon, B E Statland, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC Soft Tissue and Bone Sarcoma Group (STBSG)M Van Glabbeke, A T van Oosterom, W Steward, et al.
Acta Oncologica (Stockholm, Sweden)|November 28, 2000
A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanomaJ Baekke, C Rytter, H Mouridsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancerW Irish, B Sherrill, B Cole, et al.
Journal of Internal Medicine|September 1, 1992
Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized studyB Kristensen, B Ejlertsen, S N Holmegaard, et al.
British Journal of Cancer|July 1, 1994
Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screeningA H Andreasen, K W Andersen, M Madsen, et al.
Ugeskrift for Laeger|June 13, 2000
[Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?]N T Kroman, M B Jensen, J Wohlfahrt, et al.
Pageof 6